164 related articles for article (PubMed ID: 22996042)
21. Intracellular alpha-fetoprotein interferes with all-trans retinoic acid induced ATG7 expression and autophagy in hepatocellular carcinoma cells.
Wang S; Feng R; Shi Y; Chen D; Weng H; Ding H; Zhang C
Sci Rep; 2021 Jan; 11(1):2146. PubMed ID: 33495541
[TBL] [Abstract][Full Text] [Related]
22. Activation of the Toll‑like receptor 2 signaling pathway inhibits the proliferation of HCC cells in vitro.
Chen Y; Huang Z; Chen X; Ye H
Oncol Rep; 2019 Dec; 42(6):2267-2278. PubMed ID: 31578587
[TBL] [Abstract][Full Text] [Related]
23. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
24. Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma.
Chava S; Lee C; Aydin Y; Chandra PK; Dash A; Chedid M; Thung SN; Moroz K; Wu T; Nayak NC; Dash S
Oncotarget; 2017 Jun; 8(25):40019-40036. PubMed ID: 28402954
[TBL] [Abstract][Full Text] [Related]
25. Autophagy, NAFLD and NAFLD-Related HCC.
Wu WKK; Zhang L; Chan MTV
Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation.
Chen R; Wang H; Liang B; Liu G; Tang M; Jia R; Fan X; Jing W; Zhou X; Wang H; Yang Y; Wei H; Li B; Zhao J
Cell Death Dis; 2016 Dec; 7(12):e2512. PubMed ID: 27929538
[TBL] [Abstract][Full Text] [Related]
27. Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.
Miura K; Ishioka M; Minami S; Horie Y; Ohshima S; Goto T; Ohnishi H
J Biol Chem; 2016 May; 291(22):11504-17. PubMed ID: 27022031
[TBL] [Abstract][Full Text] [Related]
28. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
[TBL] [Abstract][Full Text] [Related]
29. Autophagy in the "inflammation-carcinogenesis" pathway of liver and HCC immunotherapy.
Yu S; Wang Y; Jing L; Claret FX; Li Q; Tian T; Liang X; Ruan Z; Jiang L; Yao Y; Nan K; Lv Y; Guo H
Cancer Lett; 2017 Dec; 411():82-89. PubMed ID: 28987386
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the Autophagy-lysosomal Pathway in Hepatocellular Carcinoma Using Small Molecules.
Lee YG; Jeon TI
Molecules; 2020 Mar; 25(7):. PubMed ID: 32235537
[TBL] [Abstract][Full Text] [Related]
31. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
[TBL] [Abstract][Full Text] [Related]
32. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
[TBL] [Abstract][Full Text] [Related]
33. Degradative autophagy selectively regulates CCND1 (cyclin D1) and MIR224, two oncogenic factors involved in hepatocellular carcinoma tumorigenesis.
Wu SY; Lan SH; Liu HS
Autophagy; 2019 Apr; 15(4):729-730. PubMed ID: 30646811
[TBL] [Abstract][Full Text] [Related]
34. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
[TBL] [Abstract][Full Text] [Related]
36. Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation.
Li W; Yue F; Dai Y; Shi B; Xu G; Jiang X; Zhou X; Pfeifer GP; Liu L
Cell Death Differ; 2019 Aug; 26(8):1379-1395. PubMed ID: 30315205
[TBL] [Abstract][Full Text] [Related]
37. BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation.
Deng G; Zeng S; Qu Y; Luo Q; Guo C; Yin L; Han Y; Li Y; Cai C; Fu Y; Shen H
J Exp Clin Cancer Res; 2018 Jul; 37(1):156. PubMed ID: 30012194
[TBL] [Abstract][Full Text] [Related]
38. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.
Inami Y; Waguri S; Sakamoto A; Kouno T; Nakada K; Hino O; Watanabe S; Ando J; Iwadate M; Yamamoto M; Lee MS; Tanaka K; Komatsu M
J Cell Biol; 2011 Apr; 193(2):275-84. PubMed ID: 21482715
[TBL] [Abstract][Full Text] [Related]
39. Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia.
Cho JH; Lee YM; Bae SH; Chou JY
Biochem Biophys Res Commun; 2020 Jan; 522(1):1-7. PubMed ID: 31735334
[TBL] [Abstract][Full Text] [Related]
40. Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy.
Inokuchi S; Yoshizumi T; Toshima T; Itoh S; Yugawa K; Harada N; Mori H; Fukuhara T; Matsuura Y; Mori M
Cancer Med; 2021 Mar; 10(5):1501-1514. PubMed ID: 33600074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
